Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa ...Middle East

BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of an exclusive license...

Read More Details
Finally We wish PressBee provided you with enough information of ( Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa )

Also on site :

• Iconic '80s Sitcom Bombshell, 66, Unrecognizable In Very Rare Sighting
• Syria’s National Authority for Transitional Justice defines its plan
• A federal judge orders the Trump administration to return a Guatemalan deported to Mexico to the US